Pharmacy Drugs
Recent Posts
- Democrats Push Medical Device Liability Bill
- FDA Investigates Heparin Link in Two Delaware Deaths
- Conflict Of Interest Reported In 29 Percent Of Cancer Studies
- Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir
- Survival For Prostate Cancer Patients Younger Than 50 Improved By Surgery
Random Posts
- Medtronic Clinical Trial Evaluating The Industry's First Cryoballoon Technology Designed For Paroxysmal Atrial Fibrillation Completes Follow Up
- Automated 'Artificial Pancreas' Controls Blood Glucose Levels In Diabetes Patients For First Time
- Shire Reports Tolerability And Clinical Effects Results Of Daytrana(R) (methylphenidate Transdermal System) From Study In Adolescents With ADHD
- Medivation Selects ProTrials To Conduct International Phase III Clinical Trials
- Archimedes Pharma Announces Ground-Breaking Phase III Data Showing NasalFent To Be Superior To The Standard Of Care For Breakthrough Cancer Pain
- Care Management Reduces Depression And Suicidal Thoughts In Older Primary Care Patients
- New Report Finds Obesity Epidemic Increases, Mississippi Weighs In As Heaviest State
- Society Launches Tools For Responsible Pharmacists
- Can Light Therapy Improve Your Sexual Functioning? New Promising Data
- Low Blood Glucose Levels Do Not Explain Excess Deaths In Accord Trial
FDA Approves Generic Prescription-Only Version Of Plan B Emergency Contraceptive For Women Ages 17 And Under
Posted by: admin in Pharmacy Drugs on June 29th, 2009
The U.S. fda.gov/” rel=”nofollow”>Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Plan B was first approved in 1999 for prescription use only for women of all ages. Plan B is manufactured by Duramed Pharmaceuticals Inc., of Cincinnati.
In 2006, Plan B was approved for nonprescription use for women ages 18 and older. Plan B remained available as a prescription-only product for women ages 17 and under. Today’s approval allows marketing of a prescription-only generic product for women ages 17 and under. No generic levonorgestrel product for emergency contraception can be approved for nonprescription use in women ages 18 and older until Aug. 24, 2009, when the marketing exclusivity held by Duramed for the nonprescription use expires.
The generic levonorgestrel tablets 0.75 mg are made by Watson Laboratories Inc., based in Corona, Calif.
Levonorgestrel can prevent pregnancy after unprotected intercourse or a known or suspected contraceptive failure. It is not effective in terminating an existing pregnancy and does not protect against sexually transmitted diseases, including HIV infection.
Source
U.S. Food and Drug Administration
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.